New Dimensions of Danger: Self-Amplifying mRNA Injections

Help More Kiwis Discover This!

Self-amplifying mRNA (sa-mRNA) injections were approved by the Japanese government in November 2023 with plans for commercial distribution to begin in October 2024. Molecular biologists Dr Hiroshi Arakawa, a researcher at the Italian Institute of Molecular Oncology in Milan and Professor Yasufumi Murakami, Vice Director at the Research Center for RNA Science, Tokyo University of Science, have been raising alarms at the plan.

Why Self-Amplifying mRNA Vaccines?

According to World Economic Forum / Gates Foundation-inspired creation, CEPI, sa-mRNA vaccines incorporate genetic information from a particular group of viruses (alphaviruses) into the sa-mRNA together with the antigen of interest (in the case of SARS CoV-2, this is the spike protein, which the immune system then learns to attack). “The genetic information from the virus programs the host cell to generate multiple copies of the saRNA, hence the term self-amplification. The amplification of the saRNA increases the number of genetic copies of the antigen [sic] and, consequently, increases the generation of the antigen protein within the host cell. This has the potential to reduce the dose of RNA needed while maintaining the effectiveness of the vaccine.“

As described by Professor Anna Blakney in conversation with Dr Jessica Rose on The Middle Way Podcast in November 2021, the main benefit of lower doses is that much more product can be manufactured at far lower cost. Professor Blakney is a biomedical engineer researching next generation RNA vaccines, including for the prevention of unintended pregnancy, at the University of British Columbia, where she is the Principal Investigator at Blakney Lab.

She received her postdoctoral fellowship at Imperial College London where she was on the team who developed a prototype Covid-19 vaccine in 14 days in March 2020. This was simultaneous to the publication of Imperial College’s dire warning under the direction of Professor Neil Ferguson using erroneous mathematical modeling, of mass death and destruction without strict lockdown measures. The conflicts of interest at Imperial and throughout academia should concern us all.

The approved Japanese product is manufactured by Meiji Holdings, partnered with CSL Seqirus and Arcturus, who are involved in the building of an mRNA drug manufacturing plant in Minamisoma city, Japan. The top ten shareholders of Meiji Holdings are exclusively banks and financial institutions. The role of powerful bankers in weakening society and establishing centralised control has been described by financial analysts such as Catherine Austin-Fitts and Richard Werner.

Why Are Scientists Ringing Alarm Bells about Self-Amplifying mRNA Vaccines?

mRNA injections instruct cells to produce antigens (in the case of covid, this is spike protein). The antigen then presents onto the cell surface, where the immune system recognises it as foreign, and attacks it. Because the attack occurs on the cell surface, the cell is also targeted, sustaining collateral damage.

The lipid nanoparticle envelopes that the mRNA is wrapped in travel throughout the body, with no way of being directed to specific cells or tissues. They can travel across delicate membranes such as the blood-brain barrier and across the placenta. Resultant risks, observed in the many vaccine injured, include but are not limited to brain, heart, vascular, immune and reproductive system harm. The absence of an “off-switch” explains why harms can occur months and even years after the last injection was administered. These mechanisms are further detailed in our 2022 article Covid-19 Vaccine Harm: Mechanisms Explained.

Self-amplifying mRNA vaccines add another dimension of danger. Instead of instructing the cell to make the antigen, they instruct the cell to make more mRNA, which then produces more of the antigen. As the amount of mRNA increases, it may sustain genetic mutations during production, and the alphaviruses used for the mRNA replication process have no proofreading or repair functions, so that mutations will not be recognised, deleted or corrected. Some experts say this is inevitable, and so will lead to the production of aberrant proteins – such as are already being seen, as in our article Frameshifting: Another Epic Modified mRNA Scandal.

Naturally-occurring RNA breaks down quickly once enough protein has been produced. mRNA injectable products are artificially modified with N1-methylpseudouridine, to delay this breakdown. Production of modified mRNA-induced proteins lacks the elegant precision of nature, and has no known off-switch.

When modified mRNA self-replicates within cells, there is a chance of mutation leading to development of a shell around the mRNA which assists the mRNA to enter cells. Small intercellular transport vesicles known as exosomes can pick up the encased mRNA and transport it to other parts of the body. Ongoing circulation throughout the body of the modified mRNA and consequent production of spike and/or aberrant proteins may exponentially increase the risks of serious harm.

Exosomes circulate in the bloodstream, but they are also released through sweat and exhaled air, meaning that there is a possibility for self-amplifying mRNA to infect others. Self-disseminating immunisation has been used in wildlife as early as the late 1990s, against Myxomatosis and Rabbit Hemorrhagic Disease.

The multiple risks associated with sa-mRNA products mean that rather than acting as a protective “vaccine”, the products may take on the nature of artificial viruses with the capacity to cause perpetual and perpetually transmissible health problems, injuries and death.

Global collaboration is needed to stop regulators from approving these dangerous toxic gene products into innocent populations. Hopefully, the world can wake up to the crime against humanity that the current mRNA vaccines represent already, without allowing the ‘next generation’ technology to amplify the damage further.